{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T04:35:23Z","timestamp":1783571723941,"version":"3.55.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,3,19]],"date-time":"2012-03-19T00:00:00Z","timestamp":1332115200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Med"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.2119\/molmed.2012.00002","type":"journal-article","created":{"date-parts":[[2012,8,7]],"date-time":"2012-08-07T19:31:32Z","timestamp":1344367892000},"page":"780-784","source":"Crossref","is-referenced-by-count":76,"title":["Fabry Disease: Incidence of the Common Later-Onset \u03b1-Galactosidase A IVS4+919G\u2192A Mutation in Taiwanese Newborns\u2014Superiority of DNA-Based to Enzyme-Based Newborn Screening for Common Mutations"],"prefix":"10.1186","volume":"18","author":[{"given":"Yin-Hsiu","family":"Chien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni-Chung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Chuan","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Desnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuh-Liang","family":"Hwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,3,19]]},"reference":[{"key":"1805780_CR1","first-page":"3733","volume":"III","author":"RJ Desnick","year":"2001","unstructured":"Desnick RJ, Ioannou YA, Eng CM. (2001) \u03b1-Galactosidase A deficiency: Fabry disease. In: The Metabolic and Molecular Bases of Inherited Disease. Vol. III. 8th ed. Scriver CR, Beaudet AL, Sly WS, Valle D, Kinzler KE, Vogelstein B (eds.). New York: McGraw-Hill, pp. 3733\u201374.","journal-title":"The Metabolic and Molecular Bases of Inherited Disease"},{"key":"1805780_CR2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.7326\/0003-4819-146-2-200701160-00148","volume":"146","author":"M Banikazemi","year":"2007","unstructured":"Banikazemi M, et al. (2007) Agalsidase-beta therapy for advanced Fabry disease: a randomized trial. Ann. Intern. Med. 146:77\u201386.","journal-title":"Ann. Intern. Med."},{"key":"1805780_CR3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1086\/422366","volume":"75","author":"WR Wilcox","year":"2004","unstructured":"Wilcox WR, et al. (2004) Long-term safety and efficacy of enzyme replacement therapy for Fabry disease. Am. J. Hum. Genet. 75:65\u201374.","journal-title":"Am. J. Hum. Genet."},{"key":"1805780_CR4","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1161\/01.CIR.0000091253.71282.04","volume":"108","author":"F Weidemann","year":"2003","unstructured":"Weidemann F, et al. (2003) Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study. Circulation. 108:1299\u2013301.","journal-title":"Circulation"},{"key":"1805780_CR5","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1002\/humu.21074","volume":"30","author":"WL Hwu","year":"2009","unstructured":"Hwu WL, et al. (2009) Newborn screening for Fabry disease in Taiwan reveals a high incidence of the later-onset GLA mutation c.936+919G<A (IVS4+919G<A). Hum. Mutat. 30:1397\u2013405.","journal-title":"Hum. Mutat."},{"key":"1805780_CR6","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1161\/CIRCGENETICS.109.862920","volume":"2","author":"HY Lin","year":"2009","unstructured":"Lin HY, et al. (2009) High incidence of the cardiac variant of Fabry disease revealed by newborn screening in the Taiwan Chinese population. Circ. Cardiovasc. Genet. 2:450\u20136.","journal-title":"Circ. Cardiovasc. Genet."},{"key":"1805780_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1086\/504601","volume":"79","author":"M Spada","year":"2006","unstructured":"Spada M, et al. (2006) High incidence of later-onset Fabry disease revealed by newborn screening. Am. J. Hum. Genet. 79:31\u201340.","journal-title":"Am. J. Hum. Genet."},{"key":"1805780_CR8","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1136\/jmg.40.8.e103","volume":"40","author":"A Morrone","year":"2003","unstructured":"Morrone A, et al. (2003) Fabry disease: molecular studies in Italian patients with X-inactivation analysis in manifesting carriers. J. Med. Genet. 40:e103\u20139.","journal-title":"J. Med. Genet."},{"key":"1805780_CR9","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s00109-005-0656-2","volume":"83","author":"R Dobrovolny","year":"2005","unstructured":"Dobrovolny R, et al. (2005) Relationship between X-inactivation and clinical involvement in Fabry heterozygotes: eleven novel mutations in the alpha-galactosidase A gene in the Czech and Slovak population. J. Mol. Med. 83:647\u201354.","journal-title":"J. Mol. Med."},{"key":"1805780_CR10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1080\/08035320600618809","volume":"95","author":"EM Maier","year":"2006","unstructured":"Maier EM, et al. (2006) Disease manifestations and X-inactivation in heterozygous females with Fabry disease. Acta. Paediatr. Suppl. 95:30\u20138.","journal-title":"Acta. Paediatr. Suppl."},{"key":"1805780_CR11","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1016\/j.jacc.2008.02.050","volume":"51","author":"GE Linthorst","year":"2008","unstructured":"Linthorst GE, Poorthuis BJ, Hollak CE. (2008) Enzyme activity for determination of presence of Fabry disease in women results in 40% false-negative results. J. Am. Coll. Cardiol. 51:2082.","journal-title":"J. Am. Coll. Cardiol."},{"key":"1805780_CR12","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.jaci.2009.04.007","volume":"124","author":"MW Baker","year":"2009","unstructured":"Baker MW, et al. (2009) Development of a routine newborn screening protocol for severe combined immunodeficiency. J. Allergy Clin. Immunol. 124:522\u20137.","journal-title":"J. Allergy Clin. Immunol."},{"key":"1805780_CR13","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1086\/339431","volume":"70","author":"S Ishii","year":"2002","unstructured":"Ishii S, et al. (2002) Alternative splicing in the alpha-galactosidase A gene: increased exon inclusion results in the Fabry cardiac phenotype. Am. J. Hum. Genet. 70:994\u20131002.","journal-title":"Am. J. Hum. Genet."},{"key":"1805780_CR14","doi-asserted-by":"publisher","first-page":"11763","DOI":"10.1073\/pnas.95.20.11763","volume":"95","author":"JY Chu","year":"1998","unstructured":"Chu JY, et al. (1998) Genetic relationship of popu lations in China. Proc. Natl. Acad. Sci. U. S. A. 95:11763\u20138.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"1805780_CR15","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1086\/302680","volume":"65","author":"B Su","year":"1999","unstructured":"Su B, et al. (1999) Y-Chromosome evidence for a northward migration of modern humans into Eastern Asia during the last Ice Age. Am. J. Hum. Genet. 65:1718\u201324.","journal-title":"Am. J. Hum. Genet."},{"key":"1805780_CR16","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1056\/NEJM199102073240607","volume":"324","author":"W Scheidt von","year":"1991","unstructured":"von Scheidt W, et al. (1991) An atypical variant of Fabry\u2019s disease with manifestations confined to the myocardium. N. Engl. J. Med. 324:395\u20139.","journal-title":"N. Engl. J. Med."},{"key":"1805780_CR17","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1056\/NEJM199508033330504","volume":"333","author":"S Nakao","year":"1995","unstructured":"Nakao S, et al. (1995) An atypical variant of Fabry\u2019s disease in men with left ventricular hypertrophy. N. Engl. J. Med. 333:288\u201393.","journal-title":"N. Engl. J. Med."},{"key":"1805780_CR18","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1046\/j.1523-1755.2003.00160.x","volume":"64","author":"S Nakao","year":"2003","unstructured":"Nakao S, et al. (2003) Fabry disease: detection of undiagnosed hemodialysis patients and identification of a \u201crenal variant\u201d phenotype. Kidney Int. 64:801\u20137.","journal-title":"Kidney Int."},{"key":"1805780_CR19","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1136\/jmg.2009.072116","volume":"47","author":"GE Linthorst","year":"2010","unstructured":"Linthorst GE, et al. (2010) Screening for Fabry disease in high-risk populations: a systematic review. J. Med. Genet. 47:217\u201322.","journal-title":"J. Med. Genet."},{"key":"1805780_CR20","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1161\/STROKEAHA.109.558320","volume":"41","author":"MA Wozniak","year":"2010","unstructured":"Wozniak MA, et al. (2010) Frequency of unrecognized Fabry disease among young European-American and African-American men with first ischemic stroke. Stroke. 41:78\u201381.","journal-title":"Stroke"},{"key":"1805780_CR21","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1136\/heartjnl-2011-300364","volume":"97","author":"P Elliott","year":"2011","unstructured":"Elliott P, et al. (2011) Prevalence of Anderson-Fabry disease in patients with hypertrophic car-diomyopathy: the European Anderson-Fabry Disease Survey. Heart. 97:1957\u201360.","journal-title":"Heart"},{"key":"1805780_CR22","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1136\/hrt.2010.200188","volume":"97","author":"AA Hagege","year":"2011","unstructured":"Hagege AA, et al. (2011) Screening patients with hypertrophic cardiomyopathy for Fabry disease using a filter-paper test: the FOCUS study. Heart. 97:131\u20136.","journal-title":"Heart"},{"key":"1805780_CR23","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1161\/01.CIR.0000012626.81324.38","volume":"105","author":"B Sachdev","year":"2002","unstructured":"Sachdev B, et al. (2002) Prevalence of Anderson-Fabry disease in male patients with late onset hy-pertrophic cardiomyopathy. Circulation. 105:1407\u201311.","journal-title":"Circulation"},{"key":"1805780_CR24","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1136\/heart.89.8.929","volume":"89","author":"SR Ommen","year":"2003","unstructured":"Ommen SR, Nishimura RA, Edwards WD. (2003) Fabry disease: a mimic for obstructive hyper-trophic cardiomyopathy? Heart. 89:929\u201330.","journal-title":"Heart"},{"key":"1805780_CR25","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1056\/NEJMoa033349","volume":"352","author":"M Arad","year":"2005","unstructured":"Arad M, et al. (2005) Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N. Engl. J. Med. 352:362\u201372.","journal-title":"N. Engl. J. Med."},{"key":"1805780_CR26","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1161\/CIRCULATIONAHA.105.593558","volume":"113","author":"H Morita","year":"2006","unstructured":"Morita H, et al. (2006) Single-gene mutations and increased left ventricular wall thickness in the community: the Framingham Heart Study. Circulation. 113:2697\u2013705.","journal-title":"Circulation"},{"key":"1805780_CR27","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1016\/j.jacc.2007.06.062","volume":"50","author":"L Monserrat","year":"2007","unstructured":"Monserrat L, et al. (2007) Prevalence of Fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 50:2399\u2013403.","journal-title":"J. Am. Coll. Cardiol."},{"key":"1805780_CR28","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s10545-010-9166-7","volume":"33","author":"HY Lin","year":"2010","unstructured":"Lin HY, et al. (2010) Enzyme assay and clinical assessment in subjects with a Chinese hotspot late-onset Fabry mutation (IVS4+919G\u2192A). J. Inherit. Metab. Dis. 33:619\u201324.","journal-title":"J. Inherit. Metab. Dis."}],"updated-by":[{"DOI":"10.2119\/molmed.2012.00002.b.erratum","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000}}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.2119\/molmed.2012.00002.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.2119\/molmed.2012.00002\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.crossref.org\/molmed.2012.00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.2119\/molmed.2012.00002.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,6]],"date-time":"2019-04-06T05:02:02Z","timestamp":1554526922000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.2119\/molmed.2012.00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,19]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["1805780"],"URL":"https:\/\/doi.org\/10.2119\/molmed.2012.00002","relation":{"erratum":[{"id-type":"doi","id":"10.2119\/molmed.2012.00002.b.erratum","asserted-by":"object"}]},"ISSN":["1076-1551","1528-3658"],"issn-type":[{"value":"1076-1551","type":"print"},{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,19]]}}}